Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-75 years of age~* type 2 diabetes mellitus, treated with stable dose of metformin and sulfonylurea for \>/= 12 weeks prior to screening~* HbA1c 7-10% at screening~* body weight stable (+/-5%) for \>/= 12 weeks prior to screening~* fasting C-peptide \>/=1ng/ml~* treatment-naïve for insulin~Exclusion Criteria:~* diagnosis or history of type 1 diabetes mellitus or secondary forms of diabetes~* acute metabolic diabetic complications or evidence of clinically significant diabetic complications~* clinically symptomatic gastrointestinal disease~* history of chronic pancreatitis or acute idiopathic pancreatitis~* \>3 episodes of severe hypoglycemia within 6 months prior to screening~* miocardial infarcion, unstable angina pectoris, coronary artery bypass surgery, post-transplantation cardiomyopathy or stroke within 6 months prior to screening~* any treatment with exenatide, exendin analogues, GLP-1 or its analogues

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: EXPERIMENTAL): None
- 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).